Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02604667 : Mechanisms of Ischemic Stroke in Cancer Patients
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria

- 18 years of age or older

- Active solid tumor cancer (for Groups 1 and 3 only)

- MRI confirmed acute ischemic stroke (for Groups 1 and 2 only)

- Available for blood draw at 48 hours (+/- 6 hours) from last known well time (for
Groups 1 and 2 only) or within 2 weeks of enrollment (for Group 3)

- Available for TCD within 2 weeks of enrollment

Exclusion Criteria

- Primary brain tumor or hematological cancer

- Treatment with intravenous or intraarterial thrombolysis or mechanical embolectomy

- Receipt of therapeutic-dose anticoagulation within 14 days

- Prior ischemic stroke

- Venous thromboembolism in past 6 months

- Platelets < 50,000/mm3

- International normalized ratio (INR) > 1.5 or Partial thromboplastin time (PTT) > 45
seconds

- Hemodialysis within 14 days

- Active pregnancy

- Infection within 14 days per Infectious Diseases Society of America (IDSA) criteria

- SIRS within 14 days
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02604667      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740